Queue Ventures raises $9.6M in private placement, with funds held in escrow until conditions are met.

Queue Ventures Ltd. announced the completion of the first closing of a brokered private placement by its subsidiary Custom FundCo Inc., raising $9.6 million through 1.2 million subscription receipts at $8.00 each. The offering, managed by Stifel Nicolaus Canada and Bloom Burton Securities, is structured so receipts convert to common shares if escrow conditions are met by June 3, 2026. Upon a business combination with Custom Health, Inc., those shares will convert into shares of the new entity. Agents received a 6% cash commission and compensation warrants. Proceeds, minus expenses, are held in escrow and will be returned if conditions aren’t met. The securities are not registered in the U.S. and may not be sold there without compliance.